SEC Company Response from AETHLON MEDICAL INC (AEMD) (CIK 0000882291) (AEMD) — Sep 29, 2017
AETHLON MEDICAL INC (AEMD) (CIK 0000882291)
Date: Sept. 29, 2017 · CIK: 0000882291 · Accession: 0001683168-17-002516
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-219589
Letter
VIA EDGAR Division of Corporate Finance Heather Percival, Esq. RE: Aethlon Medical, Inc. Registration Statement on Form S-1 Filed July 31, File No. 333-219589
Dear Mr. Mancuso and Ms. Percival:
We are writing in connection with the above-captioned matter regarding Aethlon Medical, Inc.’s (the “Company”) disclosure in its Registration Statement on Form S-1/A, filed September 29, 2017, File No. 333-219589 (the “Registration Statement”). As requested in a telephone call this morning with our counsel, Jolie Kahn, Esq., we are hereby confirming that Section 5.5 of the Securities Purchase Agreement filed as exhibit 10.84 to the Registration Statement (“SPA”) does not allow the parties to the SPA to amend the terms of the warrants (attached as exhibits 4.29 and 4.31 to the Registration Statement) without the consent of the holders of those warrants.
We hope that the foregoing is responsive to the Staff’s comments. Please do not hesitate to contact me at (858) 459-7800 (extension 300) if you have any questions regarding this matter.
Very truly yours,
AETHLON MEDICAL, INC.
Show Raw Text
CORRESP
1
filename1.htm
9635 Granite Ridge Drive
Suite 100
San Diego, CA 92123
Phone 858-459-7800
VIA EDGAR
September 29, 2017
Division of Corporate Finance
U.S. Securities and Exchange Commission
Mail Stop 4561
100 F Street N.E.
Washington, D.C. 20005
Attn:
Russell Mancuso, Esq.
Branch Chief
Heather Percival, Esq.
RE:
Aethlon Medical, Inc.
Registration Statement on Form S-1 Filed July 31,
2017
File No. 333-219589
Dear Mr. Mancuso and Ms. Percival:
We are writing in connection with the above-captioned
matter regarding Aethlon Medical, Inc.’s (the “Company”) disclosure in its Registration Statement on Form S-1/A,
filed September 29, 2017, File No. 333-219589 (the “Registration Statement”). As requested in a telephone call this
morning with our counsel, Jolie Kahn, Esq., we are hereby confirming that Section 5.5 of the Securities Purchase Agreement filed
as exhibit 10.84 to the Registration Statement (“SPA”) does not allow the parties to the SPA to amend the terms
of the warrants (attached as exhibits 4.29 and 4.31 to the Registration Statement) without the consent of the holders of those
warrants.
We hope that the foregoing is responsive
to the Staff’s comments. Please do not hesitate to contact me at (858) 459-7800 (extension 300) if you have any questions
regarding this matter.
Very truly yours,
AETHLON MEDICAL, INC.
/s/ Jim Frakes
James B. Frakes
Chief Financial Officer